Alexander A Fitzpatrick Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Alexander A Fitzpatrick.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Alexander A Fitzpatrick. Alexander A Fitzpatrick is SVP and General Counsel in KINTERA INC ($KNTA) and General Counsel and Secretary in Evofem Biosciences, Inc. ($NEOT).
Latest Insider Trading Transactions of Alexander A Fitzpatrick
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 03 2021 | NEOT | Evofem Biosciences ... | Fitzpatrick Alexander A | General Counsel and ... | Option Exercise | A | 3.25 | 150,000 | 487,500 | 150,000 | |
| Feb 03 2021 | NEOT | Evofem Biosciences ... | Fitzpatrick Alexander A | General Counsel and ... | Grant | A | 0.00 | 200,000 | 0 | 343,542 | 143.5 K to 343.5 K (+139.33 %) |
| Nov 18 2020 | NEOT | Evofem Biosciences ... | Fitzpatrick Alexander A | General Counsel and ... | Buy | P | 2.20 | 9,090 | 19,998 | 143,542 | 134.5 K to 143.5 K (+6.76 %) |
| Jun 08 2020 | NEOT | Evofem Biosciences ... | Fitzpatrick Alexander A | General Counsel and ... | Payment of Exercise | F | 3.31 | 31,590 | 104,563 | 134,452 | 166 K to 134.5 K (-19.03 %) |
| May 26 2020 | NEOT | Evofem Biosciences ... | Fitzpatrick Alexander A | General Counsel and ... | Payment of Exercise | F | 4.99 | 39,487 | 197,040 | 166,042 | 205.5 K to 166 K (-19.21 %) |
| May 08 2020 | NEOT | Evofem Biosciences ... | Fitzpatrick Alexander A | General Counsel and ... | Payment of Exercise | F | 5.24 | 7,802 | 40,882 | 205,529 | 213.3 K to 205.5 K (-3.66 %) |
| Feb 07 2020 | NEOT | Evofem Biosciences ... | Fitzpatrick Alexander A | General Counsel and ... | Option Exercise | A | 4.87 | 100,000 | 487,000 | 100,000 | |
| Feb 07 2020 | NEOT | Evofem Biosciences ... | Fitzpatrick Alexander A | General Counsel and ... | Grant | A | 0.00 | 150,000 | 0 | 213,331 | 63.3 K to 213.3 K (+236.85 %) |
| Nov 26 2019 | NEOT | Evofem Biosciences ... | Fitzpatrick Alexander A | General Counsel and ... | Payment of Exercise | F | 6.22 | 7,747 | 48,186 | 63,331 | 71.1 K to 63.3 K (-10.90 %) |
| Nov 21 2019 | NEOT | Evofem Biosciences ... | Fitzpatrick Alexander A | General Counsel and ... | Payment of Exercise | F | 5.74 | 7,747 | 44,468 | 71,078 | 78.8 K to 71.1 K (-9.83 %) |
| Oct 17 2019 | NEOT | Evofem Biosciences ... | Fitzpatrick Alexander A | General Counsel and ... | Payment of Exercise | F | 5.01 | 18,427 | 92,319 | 78,825 | 97.3 K to 78.8 K (-18.95 %) |
| Aug 26 2019 | NEOT | Evofem Biosciences ... | Fitzpatrick Alexander A | General Counsel and ... | Payment of Exercise | F | 5.13 | 1,296 | 6,648 | 97,252 | 98.5 K to 97.3 K (-1.32 %) |
| Jun 12 2019 | NEOT | Evofem Biosciences ... | Fitzpatrick Alexander A | General Counsel and ... | Payment of Exercise | F | 6.36 | 7,777 | 49,462 | 98,548 | 106.3 K to 98.5 K (-7.31 %) |
| Apr 03 2019 | NEOT | Evofem Biosciences ... | Fitzpatrick Alexander A | General Counsel and ... | Payment of Exercise | F | 3.55 | 1,298 | 4,608 | 106,325 | 107.6 K to 106.3 K (-1.21 %) |
| Oct 17 2018 | NEOT | Evofem Biosciences ... | Fitzpatrick Alexander A | General Counsel and ... | Payment of Exercise | F | 3.78 | 17,377 | 65,685 | 57,623 | 75 K to 57.6 K (-23.17 %) |
| Aug 21 2018 | NEOT | Evofem Biosciences ... | Fitzpatrick Alexander A | General Counsel and ... | Buy | P | 2.27 | 500 | 1,135 | 75,000 | 74.5 K to 75 K (+0.67 %) |
| Aug 21 2018 | NEOT | Evofem Biosciences ... | Fitzpatrick Alexander A | General Counsel and ... | Buy | P | 2.20 | 4,500 | 9,900 | 74,500 | 70 K to 74.5 K (+6.43 %) |
| Jul 03 2018 | NEOT | Evofem Biosciences ... | Fitzpatrick Alexander A | General Counsel and ... | Grant | A | 0.00 | 70,000 | 0 | 70,000 | 0 to 70 K |
| Mar 14 2018 | NEOT | Evofem Biosciences ... | Fitzpatrick Alexander A | General Counsel and ... | Option Exercise | A | 7.29 | 275,000 | 2,004,750 | 275,000 | |
| Jul 10 2008 | KNTA | KINTERA INC | Fitzpatrick Alexander A | SVP and General Cou ... | Option Exercise | D | 0.55 | 50,000 | 27,500 | 0 | |
| Jul 10 2008 | KNTA | KINTERA INC | Fitzpatrick Alexander A | SVP and General Cou ... | Option Exercise | D | 2.23 | 50,000 | 111,500 | 0 | |
| Jul 10 2008 | KNTA | KINTERA INC | Fitzpatrick Alexander A | SVP and General Cou ... | Option Exercise | D | 1.30 | 25,000 | 32,500 | 0 | |
| Jul 10 2008 | KNTA | KINTERA INC | Fitzpatrick Alexander A | SVP and General Cou ... | Option Exercise | D | 2.24 | 85,813 | 192,221 | 0 | |
| Jul 10 2008 | KNTA | KINTERA INC | Fitzpatrick Alexander A | SVP and General Cou ... | Option Exercise | D | 2.24 | 16,150 | 36,176 | 0 | |
| Jul 10 2008 | KNTA | KINTERA INC | Fitzpatrick Alexander A | SVP and General Cou ... | Option Exercise | D | 2.57 | 50,000 | 128,500 | 0 | |
| Jul 10 2008 | KNTA | KINTERA INC | Fitzpatrick Alexander A | SVP and General Cou ... | Option Exercise | D | 2.57 | 12,500 | 32,125 | 0 | |
| Jul 10 2008 | KNTA | KINTERA INC | Fitzpatrick Alexander A | SVP and General Cou ... | Option Exercise | D | 2.92 | 8,850 | 25,842 | 0 | |
| Jul 10 2008 | KNTA | KINTERA INC | Fitzpatrick Alexander A | SVP and General Cou ... | Option Exercise | D | 2.92 | 64,187 | 187,426 | 0 | |
| Jul 10 2008 | KNTA | KINTERA INC | Fitzpatrick Alexander A | SVP and General Cou ... | Sell | J | 0.00 | 1,960 | 0 | 0 | 2 K to 0 (-100.00 %) |
| Apr 03 2008 | KNTA | KINTERA INC | Fitzpatrick Alexander A | SVP and General Cou ... | Option Exercise | A | 0.55 | 50,000 | 27,500 | 362,500 | |
| Aug 02 2007 | KNTA | KINTERA INC | Fitzpatrick Alexander A | SVP and General Cou ... | Option Exercise | A | 2.23 | 50,000 | 111,500 | 312,500 |
Page: 1